R
REGENXBIO Inc. (RGNX)
NMS – Real Time Price. Currency in USD
10.91
+0.26 (2.44%)
At close: Aug 12, 2026, 3:59 PM EDT
10.91
0.00 (0.00%)
After-hours: Aug 12, 2026, 4:20 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
10.91
+0.26 (2.44%)
At close: Aug 12, 2026, 3:59 PM EDT
10.91
0.00 (0.00%)
After-hours: Aug 12, 2026, 4:20 PM EDT
No Data
There are no news for this stock.
Total debt $250.5M significantly exceeds cash reserves ($36.7M), raising financial stability concerns
Total current assets $236.2M exceed Total current liabilities $82.6M, highlighting excellent liquidity
Debt-to-equity ratio (3.5) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (4x) indicates the company easily manages its debt payments
Negative free cash flow -$63.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.86 | 6.05 | 10 | |
| Quick ratio | 2.86 | 5.63 | 10 | |
| Debt to Equity | 3.49 | 0.30 | 2.0 | |
| Debt to Assets | 0.65 | 1.04 | 3.0 | |
| Interest coverage | 3.75 | -16.91 | 9.0 | |
| Weighted average score | 6.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 113M | 90M | 83M | 170M | 174M |
| Gross Profit | 45M | 36M | 34M | 135M | 135M |
| Operating Income | -263M | -268M | -231M | -161M | -164M |
| Net Income | -280M | -263M | -227M | -194M | -196M |
| EBITDA | -250M | -251M | -215M | -146M | -149M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -11.1 | 10.13 | 4.0 |
| Next quarter | 37.44 | 33.1 | 10 |
| Current year | 12.37 | 22.1 | 8.5 |
| Next year | 39.1 | 20.96 | 10 |
| Weighted average score | 8.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 1589.64 | 125.22 | 125 | 18.63 | 9.8 |
| Y/Y | 405.73 | 132.04 | 131.16 | -26.66 | 7.8 |
| 3y average | 25.65 | 11.48 | 16.4 | 18.42 | 8.8 |
| 5y average | 41.05 | -13.97 | -19.2 | 8.97 | 4.5 |
| Weighted average score | 7.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |